Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-infectious Intermediate Posterior- or Pan-uveitis”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Large-scale testing (Phase 3)Study completedNCT00404742
What this trial is testing

LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis

Who this might be right for
Uveitis, PosteriorUveitis, IntermediatePanuveitis
Lux Biosciences, Inc. 232
Large-scale testing (Phase 3)Study completedNCT00404612
What this trial is testing

LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis

Who this might be right for
Uveitis, PosteriorUveitis, IntermediatePanuveitis
Lux Biosciences, Inc. 218
Post-approval studies (Phase 4)Study completedNCT05414201
What this trial is testing

Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-Uveitis

Who this might be right for
Non-infectious Intermediate Posterior- or Pan-uveitis
AbbVie 87
Testing effectiveness (Phase 2)Study completedNCT01900431
What this trial is testing

Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis

Who this might be right for
Uveitis
Sanofi 58
Large-scale testing (Phase 3)Ended earlyNCT01684345
What this trial is testing

Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis

Who this might be right for
Uveitis
XOMA (US) LLC 200
Large-scale testing (Phase 3)Study completedNCT01148225
What this trial is testing

The Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis

Who this might be right for
Uveitis
AbbVie 424
Large-scale testing (Phase 3)Ended earlyNCT01747538
What this trial is testing

Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment

Who this might be right for
Uveitis
XOMA (US) LLC 281
Testing effectiveness (Phase 2)Ended earlyNCT05384249
What this trial is testing

Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis

Who this might be right for
Uveitis
ACELYRIN Inc. 96
Large-scale testing (Phase 3)Ended earlyNCT02258854
What this trial is testing

An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data

Who this might be right for
Uveitis
XOMA (US) LLC 69
Testing effectiveness (Phase 2)Ended earlyNCT05953688
What this trial is testing

POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU

Who this might be right for
Uveitis Posterior Non-InfectiousUveitis, IntermediateNoninfectious Panuveitis
Alumis Inc 36
Testing effectiveness (Phase 2)Study completedNCT04706741
What this trial is testing

A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior Uveitis

Who this might be right for
Uveitis
ACELYRIN Inc. 7
Not applicableStudy completedNCT02916017
What this trial is testing

HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis

Who this might be right for
Uveitis
AbbVie 259